This organization has experienced considerable growth over the last 5 years. The company sources new innovative products for life science and R&D programs. Most of the suppliers are overseas and have become largely reliant on access to US markets.
The core customers are Government Agencies, Universities, Hospitals, and Pharma Biotech. During the 2023 calendar year, there were over 1,000 customer orders. As an operation, the employee demands are relatively simple and straightforward. However, a new ownership ground could greatly expand sales and marketing.
